Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,303.20
(
0.71%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.38
(
-0.27%
)
Bitcoin
74,280.60
(
0.46%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: tinkershaw post# 73879

Tuesday, 03/03/2009 8:49:01 PM

Tuesday, March 03, 2009 8:49:01 PM

Post# of 257253
Today’s FDA approval of Copaxone in CIS has only a very slight consequence for MNTA. It’s doubtful that many investors thought this news per se was a reason to buy.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now